Borrower record · Q2 2026
Candel Therapeutics
As filed by 2 BDCs · period end 30 June 2026NAICS 31-33 · Manufacturing
Two lenders report $46.5m of Candel Therapeutics at Q2 2026, marked at 102.9 cents. Equity/Other on all two positions whose seniority a filer disclosed.
- Filed fair value
- $46.5m
- 4 funded positions
- Reporting lenders
- 2
- across 4 filed positions
- Aggregate mark
- 102.9c
- cost filed on all 4 positions
- Maturities to
- 2030
- one date, 1 October 2030
- Periods on record
- 3
- Q4 2025 → Q2 2026
How this total is counted
- Every figure above is the sum of 4 funded positions filed by 2 BDCs, each one cited below.
- Counted from the Q2 2026 filings imported for this build, the latest of them filed 20 August 2026. A schedule filed after that date is not in these figures and will appear when the property is rebuilt.
Pricing as filed
2 floating tranches · Prime / SOFR300bp on all 2 floating tranches — every filer reports the same spread.
Capital structure
Equity/Other, on all 2 positions whose seniority a filer disclosed.
2 of 4 funded positions carry no filed seniority. Whether to classify is the filer's choice, so the unclassified value is not split here.
Rate structure
Floating, on all 2 positions whose interest type a filer disclosed.
2 of 4 funded positions carry no filed interest type.
Maturity profile
all 4 funded positions dated4.5 years to maturity, weighted by fair value across the 4 dated positions.
Filed over time
3 periods · aggregate onlyFiled fair value
Aggregate marknot to zero
Q4 2025, Q1 2026, Q2 2026 — every filer reporting the borrower at each period, aggregated. No lender is separated out at any period.
Credit flags
No lender reports this borrower on non-accrual, and no filed tranche pays in kind.
Not in the filings
- No filed seniority on 2 of 4 funded positions.
- The headline maturity range covers dated debt. 2 dated equity lines run past it and would stretch it without saying anything about the credit.
- No mark dispersion. Fewer than four filers disclosed a cost, so the distance between the highest and lowest mark would place each of them.
- No index floor filed on any tranche.
Sign up for free
Who holds it, and where they mark it.
2 lenders hold the same credit and mark it differently. Behind the gate, one row each — for this borrower and for every other one on this site, free and with no limit on how many you read.
- The spread between the highest and lowest lender mark
- Quarter-on-quarter movement across 3 periods
- Peer comparison against borrowers with the same lenders
- The 10-Q or 10-K behind every row, by accession number
Every filing behind this page
2 filers · Q2 2026| Filer | CIK | Form | Period | Filed | Accession |
|---|---|---|---|---|---|
| Eagle Point Trinity Senior Secured Lending Co | 0002027033 | 10-Q | 2026-06-30 | 2026-08-14 | 0002027033-26-000011 |
| Trinity Capital Inc. (TRIN) | 0001786108 | 10-Q | 2026-06-30 | 2026-08-05 | 0001193125-26-333907 |
Related borrowers
Same lenders
Same sector